Bajaj Allianz Pledges Direct Payments Amid Cashless Services Dispute

IMT News Desk
IMT News Desk
· 2 min read

Bajaj Allianz General Insurance has assured policyholders that it will directly settle hospitalisation bills in cases where cashless services are denied, as talks continue with hospitals to resolve a dispute raised by the Association of Healthcare Providers India (AHPI).

According to The Economic Times, AHPI recently announced plans to suspend cashless hospitalisation services for Bajaj Allianz customers starting September 1, citing disagreements over reimbursement practices. In response, Bajaj Allianz stated that even if hospitals deny cashless claims, the insurer will transfer payments directly to customers’ accounts before they are required to settle hospital bills.

Tapan Singhel, Managing Director and CEO of Bajaj Allianz, noted that the company has not received reports of cashless claim denials so far. However, he emphasised that the insurer would protect policyholders from financial stress in such cases, adding that the company’s direct settlement model – currently in place for motor insurance claims – would be adapted for health insurance policies as well.

The insurer is the fifth-largest player in India’s health insurance market, with premiums of ₹2,202 crore collected in FY26 up to July, and has tie-ups with around 25,000 hospitals. The company expressed confidence that the matter would be resolved soon, pointing to similar disputes between hospitals and other insurers that were recently settled.

Meanwhile, the General Insurance Council (GIC), the industry’s representative body, criticised AHPI’s suspension notice, stating it created unnecessary confusion among policyholders. The council warned that such disruptions could directly impact families forced to make upfront payments for treatment and could jeopardise patients’ survival in critical medical cases requiring immediate intervention.

The standoff highlights the ongoing tensions between insurers and private hospitals over reimbursement models, even as insurers seek to expand coverage and consumers increasingly rely on cashless access for health services. Industry observers note that how this dispute is resolved may set an important precedent for future negotiations between providers and insurers, particularly at a time when health insurance penetration is steadily rising in India.

Read Next

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal
News
June 9, 2026

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal

India is prepared to welcome high-quality and innovative pharmaceutical products from the global industry in exchange for preferential access for its domestic drug exports, Commerce and Industry Minister Piyush Goyal announced on Monday. Speaking at the Pharmaceutical Promotion Council Ambassadors meeting, Goyal indicated that India’s pharmaceutical market size could potentially expand to USD 120 billion […]
Article by: IMT News Desk
AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth
News
June 9, 2026

AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth

A groundbreaking study by researchers at All India Institute of Medical Sciences (AIIMS Delhi) has revealed that air pollution can damage the placenta, restrict fetal growth, and increase pregnancy complications, with effects that may extend well beyond birth. The research, published in EMBO Molecular Medicine and funded by ICMR, examined how urban air pollution impacts […]
Article by: IMT News Desk
P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses
News
June 9, 2026

P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses

P. D. Hinduja Hospital & Medical Research Centre signed a memorandum of understanding with Dr. Homi Bhabha State University (HBSU) to jointly conduct postgraduate allied (paramedical) health courses. The MoU aims to address the growing demand for skilled healthcare professionals and strengthen the quality of paramedical education in India. The program, expected to commence in […]
Article by: IMT News Desk
Immuneel Therapeutics secures over ₹100 Crore Series B Funding
News
June 9, 2026

Immuneel Therapeutics secures over ₹100 Crore Series B Funding

Immuneel Therapeutics announced the successful close of its ₹100 crore plus Series B financing. The round saw participation from new investors, including Singularity AMC, Rainmatter by Zerodha, and several High-Net-Worth Individuals, alongside strong continued support from existing investors, including Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital. The financing will directly fund key strategic priorities: […]
Article by: IMT News Desk